公开(公告)号：US11643405B2

公开(公告)日：2023-05-09

申请号：US16973443

申请日：2019-06-05

Applicant: JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD.

Inventor： Dongfang Shi ,  Changjin Fu ,  Xi Cheng ,  Weiwei Gong ,  Jie Gu ,  Pengfei Li ,  Min Zhang ,  Yan Yang ,  Wenqing Jin

IPC: C07D407/04 ,  A61P1/16 ,  A61K9/00 ,  A61K9/08

CPC classification number: C07D407/04 ,  A61P1/16 ,  A61K9/0053 ,  A61K9/08

Abstract: The invention discloses compounds for treatment or prevention of liver diseases. The compounds are compounds represented by a formula (I) or (II), optical isomers or pharmaceutically acceptable salts of the compounds. The compounds and optical isomers or pharmaceutically acceptable salts of the compounds can be applied to preparation of drugs for treatment or prevention of liver diseases.